— Know what they know.
Not Investment Advice

GRCU OTC

Global Roundtable Corporation
1W: -99.0% 1M: -99.0% 3M: +0.0% YTD: -99.0% 1Y: -99.0% 3Y: -99.8% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±8129.4%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 49 · $722675 mcap · 5.92B float · 0.0006% daily turnover · Short 65% of daily vol

Income Trends

Revenue
$1M -44.8% ▼
5Y CAGR: +48.0%
Gross Profit
$479K -65.5% ▼
5Y CAGR: +25.5%
Operating Income
-$226K -143.4% ▼
Net Income
-$243K -159.5% ▼
EPS (Diluted)
$-0.00 -134.9% ▼
EBITDA
-$186K -131.8% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$192K$136K$102K$2M$1M
YoY Growth+4.8%-29.1%-24.9%+2207.6%-44.8%
Cost of Revenue$48K$127K$27K$967K$822K
Gross Profit$143K$9K$75K$1M$479K
Gross Margin74.8%6.3%73.1%59.0%36.8%
R&D Expenses$0$0$0$0$0
SG&A Expenses$121K$518K$504K$868K$705K
Operating Expenses$121K$518K$504K$868K$705K
Operating Income$22K-$509K-$430K$521K-$226K
Operating Margin11.4%-374.8%-420.8%22.1%-17.4%
Interest Expense$12K$12K$22K$46K$17K
Income Before Tax$10K-$521K-$452K$474K-$243K
Tax Expense$0$0$0$0$0
Net Income$10K-$521K-$452K$409K-$243K
Net Margin5.3%-383.3%-442.8%17.4%-18.7%
EPS (Diluted)$0.00$-0.00$-0.00$0.00$-0.00
EBITDA$22K-$509K-$415K$586K-$186K
Shares Outstanding1.07B1.54B1.71B4.60B6.98B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms